Maintenance therapy for bipolar disorder: current and future management options

References

• Hirschfeld RM, Calabrese JR, Weissman MM et al. Screening for bipolar disorder in the community. J. Clin. Psychiatry 64, 53–59 (2003).
   Google Scholar
• Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Genet. Psychiatry 59, 530–537 (2002).
   Google Scholar
• Post RM, Denicoff KD, Leverich GS et al. Morbidity in 258 bipolar out-patients followed for 1 year with daily prospective ratings on the NIMH life chart method. J. Clin. Psychiatry 64, 680–690 (2003).
   Google Scholar
• Calabrese JR, Hirschfeld RM, Reed M et al. Impact of bipolar disorder in a US community sample. J. Clin. Psychiatry 64, 425–432 (2003).
   Google Scholar
• Coryell W, Scheftner W, Keller M et al. The enduring psychosocial consequences of mania and depression. Am. J. Psychiatry 150, 720–727 (1993).
   Google Scholar
• Vieta E. Case for caution, case for action. Bipolar Disord. 5, 434–435 (2003).
   Google Scholar
• Lam DH, Watkins ER, Hayward P et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch. Genet. Psychiatry 60, 145–152 (2003).
   Google Scholar
• Colom F, Vieta E, Reinares M et al. Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. J. Clin. Psychiatry 64, 1101–1105 (2003).
   Google Scholar
• Colom F, Vieta E, Martinez-Aran A et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch. Genet. Psychiatry 60, 402–407 (2003).
   Google Scholar
• Burgess S, Geddes J, Hawton K et al. Lithium for maintenance treatment of mood disorders (Cochrane Review). In: The Cochrane Library, Issue 1. John Wiley & Sons Ltd, UK (2004).
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Effects of lithium and its discontinuation on suicidal behaviour in bipolar manic-depressive disorders. J. Clin. Psychiatry 60(Suppl. 2), 77–84 (1999).
   Google Scholar
• Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J. Affect. Disord. 76, 257–265 (2001).
   Google Scholar
• Maj M. Diagnosis and treatment of rapidly cycling bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 251(Suppl. 2), 1162–1165 (2001).
   Google Scholar
• Solomon DA, Keitner GI, Miller IW et al. Course of illness and maintenance treatments for patients with bipolar disorder. J. Clin. Psychiatry 56, 5–13 (1995).
   Google Scholar
• Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 17, 149–173 (2003).
   Google Scholar
• Suppes T, Baldessarini RJ, Faedda GL et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch. Genet. Psychiatry 48, 1082–1088 (1991).
   Google Scholar
• Calabrese JR, Woyshville MJ. Lithium therapy: limitations and alternatives in the treatment of bipolar disorders. Ann. Clin. Psychiatry 7, 103–112 (1995).
   Google Scholar
• Brady KT. Difficulties in diagnosis and management of bipolar disorder: three case presentations. J. Clin. Psychiatry 61(Suppl. 13), 32–37 (2000).
   Google Scholar
• Bowden CL. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J. Clin. Psychiatry 59(Suppl. 6), 13–19 (1998).
   Google Scholar
• Calabrese JR, Shelton MD, Rapport DJ et al. Current research on rapid cycling bipolar disorder and its treatment. J. Affect. Disord. 67, 241–255 (2001).
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in out-patients with bipolar I depression. J. Clin. Psychiatry 60, 79–88 (1999).
   Google Scholar
• Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Genet. Psychiatry 60, 392–400 (2003).
   Google Scholar
• Calabrese JR, Bowden CL, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64, 1013–1024 (2003).
   Google Scholar
• Goldsmith DR, Wagstaff AJ, Ibbotson T et al. Spotlight on lamotrigine in bipolar disorder. CNS Drugs 18, 63–67 (2004).
   Google Scholar
• Pope HG Jr, McElroy SL, Keck PE Jr et al. Valproate in the treatment of acute mania. A placebo-controlled study. Arch. Genet. Psychiatry 48, 62–68 (1991).
   Google Scholar
• Goldberg JF, Garno JL, Leon AC et al. A history of substance abuse complicates remission from acute mania in bipolar disorder. J. Clin. Psychiatry 60, 733–740 (1999).
   Google Scholar
• Nemeroff CB. An ever-increasing pharmacopeia for the management of patients with bipolar disorder. J. Clin. Psychiatry 61(Suppl. 13), 19–25 (2000).
   Google Scholar
• Altshuler LL, Post RM, Leverich GS et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry 152, 1130–1138 (1995).
   Google Scholar
• Yatham LN, Kusumakar V, Parikh SV et al. Bipolar depression: treatment options. Can. J. Psychiatry 42(Suppl. 2), 87S–91S (1997).
   Google Scholar
• Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. 5, 407–420 (2003).
   Google Scholar
• Vieta E, Martínez-Arán A, Goikolea JM et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J. Clin. Psychiatry 63, 508–512 (2002).
   Google Scholar
• Altshuler L, Suppes T, Black D et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am. J. Psychiatry 160, 1252–1262 (2003).
   Google Scholar
• Licht RW. Drug treatment of mania: a critical review. Acta Psychiatry Scand. 97, 387–397 (1998).
   Google Scholar
• Kane JM. Tardive dyskinesia in affective disorders. J. Clin. Psychiatry 60(Suppl. 5), 43–47 (1999).
   Google Scholar
• Yatham LN. Mood stabilization and the role of antipsychotics. Int. Clin. Psychopharmacol. 17(Suppl. 3), S21–S27 (2002).
   Google Scholar
• Jibson MD, Tandon R. New atypical antipsychotic medications. J. Psychiatry Res. 32, 215–228 (1998).
   Google Scholar
• Tandon R, Jibson MD. Extrapyramidal side effects of antipsychotic treatment: scope of the problem and impact on outcome. Ann. Clin. Psychiatry 14, 123–129 (2002).
   Google Scholar
• Goodnick PJ, Jerry JM. Aripiprazole: profile on efficacy and safety. Expert Opin. Pharmacother. 3, 1773–1781 (2002).
   Google Scholar
• Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int. Clin. Psychopharmacol 9(Suppl. 5), 21–27 (1995).
   Google Scholar
• Stanniland C, Taylor D. Tolerability of atypical antipsychotics. Drug Saf. 22, 195–214 (2000).
   Google Scholar
• Owens DG. Extrapyramidal side effects and tolerability of risperidone: a review. J. Clin. Psychiatry 55(Suppl.), 29–35 (1994).
   Google Scholar
• Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multi-centre, double-blind, parallel-group study versus haloperidol. Br. J. Psychiatry 166, 712–726 (1995).
   Google Scholar
• Arvanitis LA, Miller BG. Multiple fixed doses of ‘Seroquel’ (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol. Psychiatry 42, 233–246 (1997).
   Google Scholar
• Keck PE Jr, McElroy SL. Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. J. Clin. Psychiatry 63(Suppl. 4), 3–11 (2002).
   Google Scholar
• Fagiolini A, Kupfer DJ, Houck PR et al. Obesity as a correlate of outcome in patients with bipolar disorder. Am. J. Psychiatry 160, 112–117 (2003).
   Google Scholar
• Zarate Jr CA, Tohen M, Banov MD et al. Is clozapine a mood stabilizer? J. Clin. Psychiatry 56, 108–112 (1995).
   Google Scholar
• Suppes T, Webb A, Paul B et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am. J. Psychiatry 156, 1164–1169 (1999).
   Google Scholar
• Ciapperelli A, Dell’Osso L, Bandettini di Poggio A et al. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. J. Clin. Psychiatry 64, 451–458 (2003).
   Google Scholar
• Ghaemi SN, Sachs GS. Long-term risperidone treatment in bipolar disorder: 6-month follow-up. Int. Clin. Psychopharmacol. 12, 333–338 (1997).
   Google Scholar
• Vieta E, Goikolea JM, Corbella B et al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month multicenter, open study. J. Clin. Psychiatry 62, 818–825 (2001).
   Google Scholar
• Sanger TM, Grundy SL, Gibson PJ et al. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J. Clin. Psychiatry 62, 273–281 (2001).
   Google Scholar
• Tohen M, Marneros A, Bowden C et al. Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized, double-blind, controlled, 12-month clinical trial. 3rd European Stanley Foundation Conference on bipolar disorder, Freiberg, Germany, 12–14 September (2002).
   Google Scholar
• Tohen M. Olanzapine versus placebo in relapse prevention in bipolar disorder. 156th Annual Meeting of the American Psychiatric Association, San Francisco, 17–22 May (2003).
   Google Scholar
• Tohen M, Ketter TA, Zarate CA et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry 160, 1263–1271 (2003).
   Google Scholar
• Vieta E, Reinares M, Corbella B et al. Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J. Clin. Psychopharmacol. 21, 469–473 (2001).
   Google Scholar
• Sajatovic M, Brescan DW, Perez DE et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J. Clin. Psychiatry 62, 728–732 (2001).
   Google Scholar
• Jones AM, Huizar K. Quetiapine monotherapy for mania associated with bipolar disorder [Abstract NR32]. 156th Annual Meeting of the American Psychiatric Association, CA, USA. 17–22 May (2003).
   Google Scholar
• Nejtek VA, Brown ES, Perantie D et al. Quetiapine improved mood and reduces drug cravings in bipolar, cocaine-dependent patients [Abstract I-76] 41st NCDEU Annual Meeting, Phoenix, Arizona, USA. 28–31 May (2001).
   Google Scholar
• Ghaemi SN, Goldberg JF, Ko JY et al. Quetiapine treatment of rapid-cycling bipolar disorder: an open prospective study. Bipolar Disord. 5(Suppl. 1), P73 (2003).
   Google Scholar
• Vieta E, Parramon G, Padrell E et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 4, 335–340 (2002).
   Google Scholar
• Suppes T, McElroy SL, Keck PE et al. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. Int. Clin. Psychopharmacol. 19, 173–174 (2004).
   Google Scholar
• Keck PE Jr, Versiani M, Potkin S et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry 160, 741–748 (2003).
   Google Scholar
• Keck E Jr, Marcus R, Tourkodimitris S et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry 160, 1651–1658 (2003).
   Google Scholar
• Vieta E, Bourin M, Sanchez R et al. Effectiveness of aripiprazole versus haloperidol in the treatment of patients with acute bipolar mania over a 12-week period. Br. J. Psychiatry (In Press).
   Google Scholar
• Marcus R, Carson W, McQuade R et al. Long-term efficacy of aripiprazole in the maintenance treatment of bipolar disorder. ACNP Meeting Poster, Puerto Rico (2003).
   Google Scholar
• Vieta E. Other new therapies for bipolar disorders. In: Seizures, Affective Disorders, and Anticonvulsant Drugs. Trimble MR, Schmitz B (Eds.) Clarius Press, UK, 167–180 (2002).
   Google Scholar
• Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the out-patient management of bipolar disorder. Arch. Genet. Psychiatry 60, 904–912 (2003).
   Google Scholar
• Reinares M, Vieta E, Colom F et al. Impact of a psychoeduational family intervention on caregivers of stabilized bipolar patients. Psychother. Psychosom. 73, 312–319 (2004).
   Google Scholar
• Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J. Clin. Psychiatry 63, 146–151 (2002).
   Google Scholar